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The Deficiency of PIP2 5-Phosphatase in Lowe Syndrome Affects Actin
Polymerization
Sharon F. Suchy and Robert L. Nussbaum
National Human Genome Research Institute, Bethesda
Lowe syndrome is a rare X-linked disorder characterized by bilateral congenital cataracts, renal Fanconi syndrome,
and mental retardation. Lowe syndrome results from mutations in the OCRL1 gene, which encodes a phospha-
tidylinositol 4,5 bisphosphate 5-phosphatase located in the trans-Golgi network. As a first step in identifying the
link between ocrl1 deficiency and the clinical disorder, we have identified a reproducible cellular abnormality of
the actin cytoskeleton in fibroblasts from patients with Lowe syndrome. The cellular abnormality is characterized
by a decrease in long actin stress fibers, enhanced sensitivity to actin depolymerizing agents, and an increase in
punctate F-actin staining in a distinctly anomalous distribution in the center of the cell. We also demonstrate an
abnormal distribution of two actin-binding proteins, gelsolin and a-actinin, proteins regulated by both PIP2 and
Ca+2 that would be expected to be altered in Lowe cells. Actin polymerization plays a key role in the formation,
maintenance, and proper function of tight junctions and adherens junctions, which have been demonstrated to be
critical in renal proximal tubule function, and in the differentiation of the lens. These findings point to a general
mechanism to explain how this PIP2 5-phosphatase deficiency might produce the Lowe syndrome phenotype.
The oculocerebrorenal syndrome of Lowe (OCRL [MIM
309000]) is a rare X-linked disorder caused by the de-
ficiency of a PIP2 5-phosphatase, ocrl1 (Suchy et al.
1995; Zhang et al. 1995). The discovery of the function
of ocrl1 and its subcellular localization to the Golgi (Oli-
vos-Glander et al. 1995; Dressman et al. 2000) has not
revealed how the enzyme defect leads to the bilateral
congenital cataracts, mental retardation, and renal Fan-
coni syndrome that characterize the disorder. Lowe cells
have an elevated concentration of the substrate for ocrl1,
PIP2 (Zhang et al. 1998). PIP2 is a phospholipid with a
pivotal role in a number of fundamental cell processes,
including cell signaling, protein trafficking, and polym-
erization of the actin cytoskeleton (Berridge and Irvine
1989; Toker 1996; Raucher et al. 2000). We describe
here our initial work demonstrating the novel finding
that Lowe fibroblasts have abnormalities in the actin
cytoskeleton, including decreased actin stress fibers and
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altered response to depolymerizing agents. In addition,
we report the abnormal distribution of several actin-
binding proteins that require PIP2 for optimal activity.
Because of the importance of actin in cell-cell contacts,
we expect that this cellular phenotype will help to iden-
tify a mechanism for the occurrence of the Lowe syn-
drome phenotype.
For these studies, we used fibroblast cultures from
patients with Lowe syndrome and one control culture
(PHL336) that were obtained with informed consent of
a parent or guardian (IRB protocol HG0008A and the
corresponding committee at Baylor College ofMedicine,
as described elsewhere [Lin et al. 1997b]). PIP2 phos-
phatase activities have been measured on all patients and
are !10% of normal activity. Mutations in cell lines were
described elsewhere: Lowe line 1 (XL53-01), line 2
(XL49-22), line 4 (LS60), and line 5 (PHL255) (Lin et
al. 1997b; Gropman et al. 2000); and Lowe line 6
(PHL467) and line 7 (PHL254) (Lin et al. 1998). Lowe
line 3 (PHL243) was from a patient with no detectable
OCRL1 mRNA and a deficient PIP2 5-phosphatase ac-
tivity, but the mutation has not yet been identified (au-
thors’ unpublished data). Normal cell lines were ob-
tained from the ATCC, cell line numbers CRL 1509,
CRL 1513, and CRL 1489. Cells were cultured at 37C
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Figure 1 Actin stress-fiber staining is reduced in Lowe fibroblasts. F-actin staining was assessed in Lowe and normal fibroblasts, using
Alexa 488 conjugated phalloidin to detect F-actin. Stained cells were classified into one of four types of actin staining: examples of each type
(a–d), are shown in normal cells. Scale mm. The histograms (e and f) show the results of two experiments with different Lowebarp 0.016
and normal fibroblast lines, in which 100 (e) and 220 cells (f) of each type were scored by an observer masked to the genotype. Lowe syndrome
fibroblasts had fewer cells with type a and b staining patterns and more cells with type c and d staining patterns, as compared with control
fibroblasts ( ). These results demonstrate that Lowe fibroblasts have a reduced number of long actin stress fibers.2 –11x p 38.00, df 7, P ! 10
in Dulbecco’s modified Eagle medium with 10% fetal
calf serum.
We first assessed the actin stress-fiber composition in
Lowe and normal human fibroblasts by immunofluor-
escence with phalloidin, which binds to filamentous ac-
tin (F-actin). Cells were grown on eight-well chamber
slides (NalgeneNunc) for 48 h, washed with PBS, fixed
and permeabilized with 4% buffered paraformaldehyde
and 0.1% Triton X-100 for 5 min, blocked with 5%
goat serum (NGS) for 30 min, incubated with Alexa 488
conjugated phalloidin (Molecular Probes) in PBS/1%
NGS for 1 h, mounted with Fluormount (ICN), and
photographed with a Leica epifluorescence microscope
with an Optronics MagnaFire CCD camera. To quan-
titate the staining, we scored 1100 cells of each cell line
for actin stress-fiber staining using a method reported
elsewhere (Verderame et al. 1980). This method classifies
F-actin staining into one of four patterns—a, b, c, and
d—on the basis of the number and length of actin stress
fibers: type a cells have longer, more densely packed actin
stress fibers, and type d have no detectable stress fibers.
Figure 1a–1d shows representative normal cells for each
pattern. The results of the scoring, performed blind to
the genotype, in two experiments with different Lowe
and normal fibroblast lines, are shown in figure 1e and
figure 1f. Lowe fibroblasts (lines 2 and 3) had an overall
decrease in actin stress-fiber staining with thinner and
shorter actin stress fibers that were less tightly packed.
The difference between the actin-staining patterns in
normal and Lowe cells was significant by x2 analysis,
with Lowe cells having fewer type a and b staining pat-
terns and more type c and d patterns ( , df2x p 38.00
7, ).11P ! 10
In addition to the reduced stress-fiber staining, Lowe
fibroblasts had punctate F-actin staining (fig. 2a), present
in 64% of cells, whereas only 1% of normal fibroblasts
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Figure 2 The F-actin staining pattern of Lowe cells shows a
punctate pattern in the center of the cell, essentially absent fromcontrol
cells. Lowe (a) and normal (b) fibroblasts were stained for F-actin
using a fluorescent conjugated phalloidin, as described in figure 1. Scale
mm.barp 0.02
Figure 3 Lowe fibroblasts had a more rapid response than controls to the actin depolymerizing agents, cytochalasin D and latrunculin
A. Normal (a–c) and two Lowe fibroblast lines (d–f and g–i) were stained for F-actin using fluorescent conjugated phalloidin, as described in
figure 1. Fibroblasts are shown untreated (a, d, and g) or incubated 5 min with 1 mmol cytochalasin D (b, e, and h) or with 0.24 mmol latrunculin
A (c, f, and i). Lowe cells (e, f, h, and i) showed a greater response to depolymerizing agents than did control cells (b and c). Scale barp
mm.0.02
had such punctate staining (fig. 2b). This punctate F-
actin staining was more concentrated around the nu-
cleus, as confirmed by staining with 4′,6-diamidino-2-
phenylindole (DAPI) (data not shown). Since phalloidin
binds to F-actin and not to actin monomer, the punctate
staining is due to an increase in short-actin filaments in
this region.
So that the abnormal actin stress-fiber staining in the
Lowe cells could be better understood, normal fibro-
blasts and two different Lowe fibroblast cultures were
treated with the actin depolymerizing agents cytochal-
asin D and latrunculin A. These agents depolymerize
actin primarily by blocking the addition of actin mon-
omers to the ends of actin filaments. Depolymerization
results from a net loss of monomers from filament ends;
thus the rate of depolymerization is related to the num-
ber of filament ends. Fibroblasts were treated with la-
trunculin A (Molecular Probes) (.24 mmol) and cyto-
chalasin D (1 mmol) (Sigma) for 5–30 min at 37C, were
washed with PBS, and were stained for F-actin as de-
scribed above. Higher concentrations of these agents
were also used, but they resulted in extreme depoly-
merization of actin filaments such that intact cells were
not detectable by immunofluorescence following fixa-
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Figure 4 Gelsolin staining is altered in Lowe fibroblasts. Control and two Lowe fibroblast cultures were fixed, permeabilized, and
immunostained with a monoclonal antibody to gelsolin, followed by an Alexa 594 conjugated secondary antibody. In control cells (a), gelsolin
staining was distributed along stress fibers. In Lowe fibroblasts (b and c), there was an accumulation of punctate staining in the perinuclear
area that was virtually absent in normal fibroblasts. Scale mm.barp 0.02
Figure 5 Punctate gelsolin staining in Lowe fibroblasts coincides with the punctate F-actin filament staining. Lowe fibroblasts were fixed
and incubated with a monoclonal antibody to gelsolin followed by an Alexa 594 conjugated anti-rabbit secondary antibody, along with Alexa
488 conjugated phalloidin. Fluorescence was visualized by confocal microscopy. The punctate gelsolin staining (a) and punctate F-actin staining
(b) coincided, as shown in the merged image (c). Scale mm.barp 0.02
tion and permeabilization. The earliest time point at
which there was a clear alteration in actin staining in
Lowe cells was 5 min after drug treatment; comparisons
of staining between Lowe and normal cells are therefore
shown at the 5-min time point.
Figure 3 shows untreated control (a) and Lowe cells
(lines 2 and 4) (d and g) and control and Lowe fibro-
blasts treated with cytochalasin D (b, e, and h) or la-
trunculin A (c, f, and i). Disruption of the cytoskeleton
increased with exposure time in Lowe and control cells,
but depolymerization was more rapid in the Lowe cells.
Treated Lowe fibroblasts, shown in figure 3 (e, f, h, and
i), had a reduction in F-actin staining in almost all cells,
with fewer long actin filaments and an increased number
of short filaments. Conversely, normal cells had only a
slight change in stress-fiber staining after the short treat-
ment, and many of the cells showed a staining pattern
indistinguishable from untreated cells (fig. 3b and 3c).
The more rapid response of Lowe fibroblasts to these
agents indicated that Lowe cells had more filament ends
and may have an increase in actin-severing activity.
Gelsolin is a major actin-severing protein regulated by
PIP2 and Ca
2 (Janmey and Stossel 1987; Janmey 1994;
Lin et al. 1997a). Elevated levels of PIP2 in Lowe cells
(Zhang et al. 1998) may lead to local alterations in Ca2
levels through the activity of phospholipase C, by which
PIP2 is metabolized to inositol trisphosphate and dia-
cylglycerol, leading to the release of calcium from in-
tracellular stores. Consequently, we investigatedwhether
Lowe cells had a change in the distribution of gelsolin
by immunofluorescence (fig. 4), performed essentially as
for the actin staining above, except that the cells were
incubated with gelsolin monoclonal antibody (Sigma) in
PBS with 1% NGS for 1 h, followed by a 1-h incubation
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Figure 6 Distribution of the punctate gelsolin staining does not colocalize with the TGN but does overlap with that of an ER marker.
Lowe fibroblasts (a–c) were fixed and incubated with a monoclonal antibody to gelsolin and a polyclonal antibody to the mannose 6-phosphate
receptor (M6-PR), followed by an Alexa 594 conjugated anti-mouse secondary antibody and an Alexa 488 conjugated anti-rabbit secondary
antibody. The gelsolin staining (a) did not overlap with that of the TGN marker, M6-PR (b), as seen in the merged image (c). Scale barp
mm. The localization of the punctate gelsolin staining was further studied (d–f) by double-labeling Lowe fibroblasts, as described above,0.06
with anti-gelsolin antibody and with Alexa 488 conjugated concanavalin A, a probe for the endoplasmic reticulum. Fluorescence was visualized
by confocal microscopy (d–f), scale mm. The gelsolin staining (d) and the concanavalin A staining (e) partially overlapped, asbarp 0.063
shown in the merged image (f).
with an Alexa 594-anti-mouse IgG (Molecular Probes).
In control cells, gelsolin staining was present along stress
fibers and at the plasma membrane, as reported else-
where, along with a diffuse nuclear staining (Dissmann
and Hinssen 1994) (fig. 4a). In Lowe fibroblasts (lines
2 and 5), in addition to the stress-fiber staining, there
was a redistribution of gelsolin staining in a punctate
pattern in the center of the cell (fig. 4b, and 4c). This
punctate staining was virtually absent from normal fi-
broblasts. We have confirmed these observations in three
additional Lowe fibroblast lines (data not shown). The
fact that the same punctate gelsolin staining was ob-
served in the six lines from patients with Lowe syndrome
that were tested, including three withmissensemutations
that abolished PIP2 5-phosphatase activity but had ocrl1
protein detectable by western analysis (Lin et al. 1997b,
1998; Gropman et al. 2000), indicates that the PIP2 5-
phosphatase activity is responsible for the actin abnor-
mality reported here.
Gelsolin not only severs actin filaments but also caps
filament ends after severing. To assess whether the punc-
tate staining observed in Lowe fibroblasts represented
free gelsolin or gelsolin bound to short actin filaments,
we double-labeled Lowe fibroblasts (line 5) using phal-
loidin and anti-gelsolin antibody and photographed cells
with a Zeiss Axiovert 100 confocal microscope. The
punctate gelsolin staining (fig. 5a) coincided with punc-
tate F-actin staining (fig. 5b), in merged images (fig. 5c),
indicating that, in this region, the short actin filaments
were associated with and possibly capped by gelsolin.
This points to the possibility that there is a localized
increase in gelsolin activity in Lowe fibroblasts.
To determine whether the punctate gelsolin staining
in Lowe cells overlapped with the trans-Golgi network
(TGN), where ocrl1 is localized in normal cells, we per-
formed double-label immunofluorescence in Lowe cells
with gelsolin antibody and a polyclonal antibody to the
TGN-localized mannose 6-phosphate receptor (M6-PR),
kindly provided by Dr. J. Paul Luzio (Cambridge Uni-
versity) (fig. 6a–6c). M6-PR localized to a condensed
region in the perinuclear area of the cell (line 5) (fig.
6b), whereas the punctate gelsolin staining (fig. 6a) ap-
peared in a broader area around the nucleus. In merged
images, it was clear that the punctate gelsolin staining
was completely excluded from the TGN identified by
the M6-PR antibody (fig. 6c). Because of the broader
cytoplasmic distribution of the punctate gelsolin stain-
ing, we double-labeled the cells with an antibody to gel-
solin (fig. 6d) (line 6) and Alexa 488 concanavalin A as
a probe for the endoplasmic reticulum (ER) (fig. 6e)
(Miralles et al. 1993; Ofner and Hooper 2002). By con-
focal imaging, we saw a clear overlap of the staining
pattern in the merged image (yellow staining, fig. 6f),
demonstrating that the punctate gelsolin staining over-
lapped the ER.
To confirm that ocrl1 expression was responsible for
the punctate gelsolin staining, Lowe fibroblasts that had
previously shown to have no detectable OCRL1 mRNA
(Olivos-Glander et al. 1995) were transfected with
OCRL1 cDNA in a mammalian expression vector. Fi-
Reports 1425
Figure 7 Lowe cells transfected with ocrl1 cDNA are lacking the punctate gelsolin staining seen in most untransfected fibroblasts. Images
show gelsolin staining of transfected (arrows) and untransfected cells. Following transfection, cells were plated, fixed, and double-labeled with
an antibody to ocrl1, to identify transfected cells, and with gelsolin antibody. Scale mm.barp 0.05
broblasts from patients with Lowe syndrome (7 # 105
cells) were transfected with 2 mg of OCRL1 cDNA (Oli-
vos-Glander et al. 1995) with the Amaxa Biosystems
NHDF-Neo Nucleofector kit using the manufacturer’s
optimized protocol for human fibroblasts. Cells were
plated immediately after transfection onto polylysine-
coated glass slides (Nunc), and immunofluorescencewas
performed after 24–48 h (as described above) with anti-
gelsolin monoclonal antibody and ocrl1 polyclonal
antibody.
Transfected Lowe fibroblasts were scored for expres-
sion of ocrl1. Transfection efficiency in different exper-
iments, with two different Lowe cell lines (line 1 and
line 2), was estimated by comparing the percentage of
ocrl1 stained cells to total cells in several fields, which
ranged from 1% to 12%, although, in most experiments,
efficiency was 1%–2%. This efficiency is significantly
lower than that reported by the manufacturer. According
to the manufacturer, their transfection efficiency exper-
iments were done with first passage newborn dermal
fibroblasts and might be diminished considerably by the
age of the donor, the passage number of the cell line,
the length of time the cell line had been frozen, and the
plasmid used in transfections. Although the punctate
staining was present in the majority of untransfected
fibroblasts (fig. 7a–7d), as described above, no trans-
fected cells (fig. 7, arrows) had punctate staining (fig.
7a–7d). In the experiment shown here, both transfected
and untransfected cells appeared to have reduced stress-
fiber staining.
Additional actin-binding proteins were studied in nor-
mal and Lowe fibroblasts: profilin, cofilin, vinculin, vil-
lin, and a-actinin. Of these, only a-actinin was found
to have an abnormal staining pattern in Lowe fibro-
blasts. For a-actinin immunofluorescence, cells were
fixed for 5 min with cold (20C) methanol, washed,
blocked, and incubated with primary and secondary an-
tibodies (as described above) using a-actininmonoclonal
antibody (Sigma), followed by Alexa 488–anti-mouse
IgM. Cells of both genotypes displayed an even distri-
bution of the a-actinin protein along actin stress fibers
and concentrated at focal adhesions and at the plasma
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Figure 8 Immunofluorescence staining of a-actinin is altered in Lowe fibroblasts. Control and two Lowe fibroblast cultures were fixed,
permeabilized, and immunostained with a monoclonal antibody to a-actinin followed by an Alexa 488 conjugated secondary antibody. In
control cells (a), a-actinin staining was present at focal adhesions and along stress fibers. In Lowe fibroblasts (b and c), there was an accumulation
of punctate staining in the perinuclear area that was virtually absent in normal fibroblasts. Scale mm.barp 0.05
membrane (fig. 8a–8c), as reported elsewhere (Edlund
et al. 2001). However, in addition to this staining, Lowe
fibroblasts showed a distinctly abnormal accumulation
of punctate staining in the center of the cell in ∼61% of
Lowe fibroblasts (fig. 8b and 8c) (lines 2 and 1), whereas
only 4% of normal fibroblasts had similar staining. It
is interesting that a-actinin activity, like that of gelsolin,
is dependent upon PIP2 and Ca
2. Double-label immu-
nofluorescence studies to determine whether the punc-
tate a-actinin and gelsolin staining overlapped were un-
successful, since the a-actinin and the gelsolin antibodies
were both mouse monoclonals, and the optimum fixa-
tion conditions for the detection of a-actinin staining
were not compatible with detection of gelsolin staining.
We found alterations in the actin cytoskeleton in Lowe
fibroblasts: a reduction in number and length of actin
stress fibers and an altered distribution of two actin-
binding proteins, gelsolin, and a-actinin. These abnor-
malities are a consequence of elevated PIP2 levels (and
possibly of local increases in Ca2) that may be present
in particular subcellular domains. This novel cellular
phenotype is likely to be a contributory cause of the
clinical phenotype in Lowe syndrome. Further study will
be necessary to determine the precise relationship be-
tween the cellular and clinical phenotypes and why only
certain tissues are affected. Certain cell types or subcel-
lular structures may be more susceptible to chronic ab-
normalities in actin or actin-binding proteins. Two of
the major defects in Lowe syndrome appear to be in
renal and lens epithelium, leading to renal tubular dys-
function and a failure of the primary lens fiber cell dif-
ferentiation (Nussbaum and Suchy 2001). It has been
shown that epithelial cell adhesion requires interaction
of actin with actin-binding proteins such as E-cadherin
and a-catenin (Adams et al. 1998; Vasioukhin et al.
2000), and that these cell-cell contacts fail to form when
actin polymerization is disrupted (Vasioukhin et al.
2000). Actin polymerization plays a key role in the for-
mation, maintenance, and proper functioning of tight
junctions in cultured kidney epithelium (Stevenson and
Begg 1994; Wittchen et al. 1999) that are required for
normal barrier function of the renal proximal tubule
cells (Cereijido et al. 1993). Remodeling of the cytoske-
leton has also been demonstrated to be essential for lens
differentiation (Lee et al. 2000), and the lens fails to
develop properly when F-actin and cell-adhesion mol-
ecules fail to organize at membranes (Ferreira-Cornwell
et al. 2000).
We hypothesize that Lowe syndrome may result from
a chronic deficiency of a PIP2 5-phosphatase, localized
to the TGN (Dressman et al. 2000), with a consequent
elevation of PIP2 that can effect the actin cytoskeleton
and, in turn, the formation and maintenance of certain
cell-cell contacts. The identification of this cellular phe-
notype provides a model system to test possible inter-
ventions in the disease process and perhaps to interrupt
pathogenesis in this disorder.
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